- Home
- REGCP vs BRTX Comparison
REGCP vs BRTX Comparison
Compare REGCP & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REGCP
- BRTX
- Stock Information
- Founded
- REGCP N/A
- BRTX 1997
- Country
- REGCP United States
- BRTX United States
- Employees
- REGCP 497
- BRTX N/A
- Industry
- REGCP
- BRTX Managed Health Care
- Sector
- REGCP
- BRTX Health Care
- Exchange
- REGCP Nasdaq
- BRTX Nasdaq
- Market Cap
- REGCP N/A
- BRTX 11.3M
- IPO Year
- REGCP N/A
- BRTX N/A
- Fundamental
- Price
- REGCP $23.75
- BRTX $1.44
- Analyst Decision
- REGCP
- BRTX Strong Buy
- Analyst Count
- REGCP 0
- BRTX 1
- Target Price
- REGCP N/A
- BRTX $18.00
- AVG Volume (30 Days)
- REGCP N/A
- BRTX 100.2K
- Earning Date
- REGCP N/A
- BRTX 11-12-2024
- Dividend Yield
- REGCP N/A
- BRTX N/A
- EPS Growth
- REGCP N/A
- BRTX N/A
- EPS
- REGCP N/A
- BRTX N/A
- Revenue
- REGCP N/A
- BRTX $377,000.00
- Revenue This Year
- REGCP N/A
- BRTX $482.76
- Revenue Next Year
- REGCP N/A
- BRTX $212.24
- P/E Ratio
- REGCP N/A
- BRTX N/A
- Revenue Growth
- REGCP N/A
- BRTX 189.55
- 52 Week Low
- REGCP N/A
- BRTX $1.03
- 52 Week High
- REGCP N/A
- BRTX $3.67
- Technical
- Relative Strength Index (RSI)
- REGCP 45.08
- BRTX 54.72
- Support Level
- REGCP $23.30
- BRTX $1.48
- Resistance Level
- REGCP $23.59
- BRTX $1.58
- Average True Range (ATR)
- REGCP 0.22
- BRTX 0.08
- MACD
- REGCP 0.01
- BRTX 0.01
- Stochastic Oscillator
- REGCP 50.45
- BRTX 75.00
About REGCP Regency Centers Corporation
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.